Insider · CIK 0001410236
Carol C. Lam
Files at TCON (Tracon Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Carol C. Lam files SEC Form 4 as director at TCON (Tracon Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carol C. Lam has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 19, 2023 | TCON Tracon Pharmaceuticals, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +18,000 | $0.00 | $0 | 18,000 | Apr 21, 2023 |
Questions about Carol C. Lam
Answered from the filings on this page, as of the latest one.
Is Carol C. Lam buying or selling?
Carol C. Lam has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carol C. Lam's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carol C. Lam has 0.
Where does Carol C. Lam file Form 4?
Carol C. Lam has filed Form 4 at TCON (Tracon Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.